Forte Biosciences, Inc.

NasdaqCM FBRX

Forte Biosciences, Inc. Dividend Per Share for the Trailing 12 Months (TTM) ending September 30, 2024: USD -0.00

Forte Biosciences, Inc. Dividend Per Share is USD -0.00 for the Trailing 12 Months (TTM) ending September 30, 2024, a 0.00% change year over year. Dividend per share represents the dividends distributed per share. Indicates dividend yield potential on a per-share basis.

Forte Biosciences, Inc. Dividend Per Share for the Trailing 12 Months (TTM) ending September 30, 2023 was USD -0.00.
Forte Biosciences, Inc. Dividend Per Share for the Trailing 12 Months (TTM) ending September 30, 2021 was USD -0.00, a 0.00% change year over year.
Forte Biosciences, Inc. Dividend Per Share for the Trailing 12 Months (TTM) ending September 30, 2020 was USD -0.00, a 0.00% change year over year.

Key data

Date	Dividend Per Share	Free Cash Flow Per Share	Return on Assets (ROA)	Return on Equity (ROE)

NasdaqCM: FBRX

Forte Biosciences, Inc.

CEO	Dr. Paul A. Wagner Ph.D.
IPO Date	April 13, 2017
Location	United States
Headquarters	3060 Pegasus Park Drive
Employees	11
Sector	Health Care
Industries Biotechnology Pharmaceuticals

Description

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

Key trends

Past 5 years